0001415889-23-011175.txt : 20230717 0001415889-23-011175.hdr.sgml : 20230717 20230717180251 ACCESSION NUMBER: 0001415889-23-011175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moss Dana J CENTRAL INDEX KEY: 0001985665 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 231092545 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 4 1 form4-07172023_100748.xml X0508 4 2023-07-11 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001985665 Moss Dana J 4995 BRADENTON AVE, SUITE 240 DUBLIN OH 43017 true false false false 0 Common Stock 2023-07-11 4 A 0 250000 0 A 250000 D Shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan. /s/ Gioia Gentile for Dana J. Moss, by power of attorney 2023-07-17